| Vifor Fresenius Medical Care Renal Pharma Ltd. - Rayaldee 30 µg, Weichkapseln retardiert | | 67614 | | 01 | | Rayaldee 30 µg | | Weichkapseln retardiert | | H05BX05 | | Calcifediol | | 22.12.2020 | | |
| | Composition | | calcifediolum 30 µg ut calcifediolum monohydricum, paraffinum solidum, paraffinum liquidum, hypromellosum, glyceroli monostearas 40-55, macrogolglyceridorum laurates, ethanolum anhydricum 3.944 mg, E 321, Kapselhülle: amylum hydroxypropylum, carrageenanum, sorbitolum liquidum partim deshydricum corresp. sorbitolum 18 mg, dinatrii phosphas corresp. natrium 0.3 mg, titanii dioxidum, E 133, aqua purificata pro capsula. | | Packungsbestandteile | | Weichkapseln retardiert | | | | | Principe actif | Concentr. |
|---|
| Calcifediolum | 30 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Calcifediolum | 30 mcg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Amylum Hydroxypropylum | | Kapselhülle | | Aqua Purificata pro Capsula | | | | Carrageenanum | | | | Disodium Phosphate | | | | E 133 | | color. | | E 321 | | | | Ethanol Anhydrate | 3.944 mg | | | Glyceroli Monostearas | 40-55 | | | Hypromellosum | | | | Macrogolglyceridorum Laurates | | | | Paraffine Liquide | | | | Paraffinum Solidum | | | | Sorbitolum Liquidum Partim Deshydricum | | | | Titanium Dioxide | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | 88.18 | 112.30 | B | LS | Oui |
|
|
